Yes. Our patented detection technology captures the onset and offset of every arrhythmia, accurately detecting atrial fibrillation as well as identifying complex ventricular ectopy such as ventricular tachycardia (VT), supraventricular tachycardia (SVT), bigeminy, and trigeminy.
Yes. True full disclosure™ means every one of your patient’s heartbeats is captured, transmitted, annotated, and analyzed for all modalities.
No. To make the best decisions about next steps of care, you need daily actual PVC and PAC counts with no extrapolations. The VT/SVT summary of our At-a-Glance Clinical Reference View gives you an ectopic beat analysis detailed down to single ectopic beats, as well as couplets, triplets, and runs—giving you complete visibility into burden trends.
Yes. Other devices can create delays in transmitting data, leading to diagnoses that take as long as two to three weeks, but MediLynx gives you the near-real time data you need to do intra-study interventions.